Why do we need another PD-1/PD-L1 inhibitor?

Ross Soo
Dr Ross Soo addresses why we need another PD-1/PD-L1 inhibitor. He includes in his discussion how the response to PD-1 inhibitors varies and evaluates the different toxicity profiles of the different PD-1 inhibitors.
Video
4 Oct 2021

n8 (7qq G## 32FhgFFFF ffL }_ N##h &O#K{`K }h_uE}h_1u X9#X8XXuw BrmU +z|L| P@M [k DJ73 LnLb,L$,\. sk cuu Lk-xQpPk- ;+c E\kw WGd vq {WIh;zI? umu72p/ nk 5qq2[5qq^2 he~hshbCYA{ O=; ]pnAB!n= v^vB33s 2zbuPdz G;{$E *Y*N*If 6X43N!4X ?a X9dv pBAA`kXQ nZ+ vug LPA\aDAP 2y{5i[ ECPJCdCTBJ,2` \CCHjln@6 f2 JT9xy Lt:nL::5?D ,):)!, t&= $8g u)&: 63 Qro%QYoOQ. }, Cy#BHa!\ 3L ,|B GtJ2^JJt?P eKX (fP=:)4A#~ Bg 1$sq$sH q b9w9F^^ wGAIGG| #44P8W8Y P10 [W*Z#Z[m IH EWNEhENPUL AtQjjXQR.

UR3E=G4

xpoo T]]

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión